Literature DB >> 19400112

Discovery and optimization of a TRAIL R2 agonist for cancer therapy.

Yvonne M Angell1, Ashok Bhandari, M Nuria De Francisco, Brian T Frederick, Jennifer M Green, Karen Leu, Kerstin Leuther, Reuben Sana, Peter J Schatz, Erik A Whitehorn, Kathy Wright, Christopher P Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19400112     DOI： 10.1007/978-0-387-73657-0_45

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

Review 1.  Post-complexation Functionalization of Cyclometalated Iridium(III) Complexes and Applications to Biomedical and Material Sciences.

Authors:  Shin Aoki; Kenta Yokoi; Yosuke Hisamatsu; Chandrasekar Balachandran; Yuichi Tamura; Tomohiro Tanaka
Journal:  Top Curr Chem (Cham)       Date:  2022-08-10

2.  Clustering of Death Receptor for Apoptosis Using Nanoscale Patterns of Peptides.

Authors:  Yang Wang; Igor Baars; Ferenc Fördös; Björn Högberg
Journal:  ACS Nano       Date:  2021-05-21       Impact factor: 18.027

3.  Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death.

Authors:  Abdullah-Al Masum; Yosuke Hisamatsu; Kenta Yokoi; Shin Aoki
Journal:  Bioinorg Chem Appl       Date:  2018-08-01       Impact factor: 7.778
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.